Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection In Vitro F Curreli, SMB Victor, S Ahmed, A Drelich, X Tong, CTK Tseng, CD Hillyer, ... MBio 11 (6), 10.1128/mbio. 02451-20, 2020 | 58 | 2020 |
Preclinical optimization of gp120 entry antagonists as anti-HIV-1 agents with improved cytotoxicity and ADME properties through rational design, synthesis, and antiviral evaluation F Curreli, S Ahmed, SM Benedict Victor, IR Iusupov, DS Belov, PO Markov, ... Journal of medicinal chemistry 63 (4), 1724-1749, 2020 | 34 | 2020 |
Design, synthesis, and antiviral activity of a series of CD4-mimetic small-molecule HIV-1 entry inhibitors F Curreli, S Ahmed, SMB Victor, IR Iusupov, EA Spiridonov, DS Belov, ... Bioorganic & medicinal chemistry 32, 116000, 2021 | 10 | 2021 |
Identification of combinations of protein kinase C activators and histone deacetylase inhibitors that potently reactivate latent HIV F Curreli, S Ahmed, SMB Victor, AK Debnath Viruses 12 (6), 609, 2020 | 8 | 2020 |
Discovery of highly potent fusion inhibitors with potential Pan-coronavirus activity that effectively inhibit major COVID-19 variants of concern (VOCs) in Pseudovirus-based assays F Curreli, S Ahmed, SMB Victor, A Drelich, SS Panda, A Altieri, AV Kurkin, ... Viruses 14 (1), 69, 2021 | 6 | 2021 |
Discovery of highly potent pancoronavirus fusion inhibitors that also effectively inhibit COVID-19 variants from the UK (Alpha), South Africa (Beta), and India (Delta) F Curreli, S Ahmed, SMB Victor, A Drelich, SS Panda, A Altieri, AV Kurkin, ... | | 2021 |
Discovery of highly potent pancoronavirus fusion inhibitors that also effectively inhibit COVID-19 variants from the UK and South Africa F Curreli, S Ahmed, SMB Victor, A Drelich, SS Panda, A Altieri, AV Kurkin, ... bioRxiv, 2021.09. 03.458877, 2021 | | 2021 |